Question: why was iproniazid withdrawn from the market in 1961?
Answer: Unfortunately, iproniazid had to be withdrawn from the market in 1961 because of what was considered an unacceptable incidence of hepatitis (Kline 1970; Kline and Cooper 1980; Kauffman 1979). Other MAOIs were subsequently introduced and studied extensively.